MXPA02002251A - Diagnosticos y terapeuticos para osteoporosis. - Google Patents

Diagnosticos y terapeuticos para osteoporosis.

Info

Publication number
MXPA02002251A
MXPA02002251A MXPA02002251A MXPA02002251A MXPA02002251A MX PA02002251 A MXPA02002251 A MX PA02002251A MX PA02002251 A MXPA02002251 A MX PA02002251A MX PA02002251 A MXPA02002251 A MX PA02002251A MX PA02002251 A MXPA02002251 A MX PA02002251A
Authority
MX
Mexico
Prior art keywords
osteoporosis
therapeutics
diagnostics
identification
subject
Prior art date
Application number
MXPA02002251A
Other languages
English (en)
Inventor
Van Dijk Simon
Original Assignee
Interleukin Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interleukin Genetics Inc filed Critical Interleukin Genetics Inc
Publication of MXPA02002251A publication Critical patent/MXPA02002251A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA02002251A 1999-08-30 2000-08-30 Diagnosticos y terapeuticos para osteoporosis. MXPA02002251A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15146099P 1999-08-30 1999-08-30
PCT/US2000/023844 WO2001016377A2 (en) 1999-08-30 2000-08-30 Diagnostics and therapeutics for osteoporosis

Publications (1)

Publication Number Publication Date
MXPA02002251A true MXPA02002251A (es) 2003-08-20

Family

ID=22538869

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02002251A MXPA02002251A (es) 1999-08-30 2000-08-30 Diagnosticos y terapeuticos para osteoporosis.

Country Status (11)

Country Link
US (2) US6558905B1 (es)
EP (1) EP1212464B1 (es)
JP (1) JP2004504802A (es)
AT (1) ATE318328T1 (es)
AU (2) AU785040B2 (es)
BR (1) BR0014150A (es)
CA (1) CA2382848C (es)
DE (1) DE60026150T2 (es)
ES (1) ES2261239T3 (es)
MX (1) MXPA02002251A (es)
WO (1) WO2001016377A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1194590A2 (en) * 1999-06-30 2002-04-10 Interleukin Genetics, Inc. Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype
US20090023147A1 (en) * 1999-08-30 2009-01-22 Kenneth Kornman Diagnostics and therapeutics for osteoporosis
KR20040026665A (ko) * 2001-06-15 2004-03-31 인터레우킨 제네틱스, 인코포레이티드 노화 관련 증상의 조기 개시를 검출 및 치료하는 방법
US20070264645A1 (en) * 2002-01-25 2007-11-15 Kenneth Kornman IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes
WO2003064600A2 (en) * 2002-01-25 2003-08-07 Interleukin Genetics, Inc. The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes
AU2003265676A1 (en) * 2002-08-24 2004-03-11 Creighton University Methods for detecting genes associated with bone properties and/or height
CA2512549A1 (en) * 2003-01-16 2004-08-05 Decode Genetics Ehf. Methods for diagnosing osteoporosis or a susceptibility to osteoporosis based on haplotype association
CN1863928A (zh) * 2003-08-08 2006-11-15 英特利金遗传学有限公司 骨质疏松的诊断和治疗
US7353662B2 (en) * 2004-12-22 2008-04-08 York International Corporation Medium voltage starter for a chiller unit
US8590329B2 (en) 2004-12-22 2013-11-26 Johnson Controls Technology Company Medium voltage power controller
US8105775B2 (en) * 2005-10-25 2012-01-31 Interleukin Genetics, Inc. IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes
EP2089538B1 (en) * 2006-11-15 2013-08-21 Interleukin Genetics, Inc. The il-1 gene cluster and insulin resistance: associated polymorphisms, haplotypes and methods of using same
JP2019503176A (ja) 2016-01-12 2019-02-07 インターロイキン ジェネティクス， インコーポレイテッド 処置に対する応答を予測するための方法
US10329620B2 (en) 2017-01-12 2019-06-25 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
US20220249660A1 (en) 2019-06-06 2022-08-11 Sitokine Limited Compositions and methods for treating lung, colorectal and breast cancer
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311018D0 (en) 1983-04-22 1983-05-25 Amersham Int Plc Detecting mutations in dna
CA1316520C (en) 1987-05-19 1993-04-20 Larry C. Hamilton Valve
FR2650840B1 (fr) 1989-08-11 1991-11-29 Bertin & Cie Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications
WO1993011149A1 (en) 1991-12-03 1993-06-10 Thomas Jefferson University Methods of detecting a genetic predisposition for osteoporosis
EP0652975B1 (en) 1992-07-31 2004-10-13 Garvan Institute Of Medical Research Assessment of trans-acting factors allelic variation
JPH08505149A (ja) 1992-12-28 1996-06-04 ジェイ． ベイリンク，デビッド 骨再吸収検定法
IL108947A0 (en) 1993-03-12 1994-06-24 Osteopharm Ltd Bone stimulating factor
CA2164498C (en) 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
US5698399A (en) * 1996-04-05 1997-12-16 Duff; Gordon W. Detecting genetic predisposition for osteoporosis
GB9706359D0 (en) * 1997-03-27 1997-05-14 Gemini International Holdings Polymorphisms of an il-1 receptor antagonist gene
GB9711040D0 (en) * 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease

Also Published As

Publication number Publication date
DE60026150T2 (de) 2006-11-16
AU785040B2 (en) 2006-08-31
AU7338000A (en) 2001-03-26
ATE318328T1 (de) 2006-03-15
DE60026150D1 (de) 2006-04-27
US20040110168A1 (en) 2004-06-10
WO2001016377A2 (en) 2001-03-08
BR0014150A (pt) 2002-05-14
ES2261239T3 (es) 2006-11-16
EP1212464A2 (en) 2002-06-12
EP1212464B1 (en) 2006-02-22
AU2006203097B2 (en) 2009-03-12
CA2382848A1 (en) 2001-03-08
JP2004504802A (ja) 2004-02-19
US6558905B1 (en) 2003-05-06
WO2001016377A3 (en) 2002-01-17
CA2382848C (en) 2011-01-04
AU2006203097A1 (en) 2006-08-17

Similar Documents

Publication Publication Date Title
MXPA02002251A (es) Diagnosticos y terapeuticos para osteoporosis.
EP1439796B8 (en) Areal implant
HK1020099A1 (en) Adjustable shoulder rest for violins or the like.
ZA996185B (en) Sulfanylsilanes.
ZA99452B (en) Antibodies against human IL-12.
MXPA04004939A (es) 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3-alquilados y 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3,3??-dialquilados y procesos para su fabricacion.
ZA991272B (en) Novel thiobenzamides.
ZA995806B (en) Integrated direct reduction iron system.
ZA200005786B (en) Dragline rigging system.
ZA992443B (en) Hydroxy-methyl-hexanones.
ZA989536B (en) Medical face mask.
ZA994918B (en) New ketones.
ZA200001456B (en) Transaction apparatus.
ZA995325B (en) Methylcyclotetradec-5-en-1-ones.
ZA993123B (en) Trisresorcinyltriazines.
MXPA03002926A (es) Proceso para la sintesis de 2,2,6,6,-tetrametil-4--oxipiperidina.
AP2001002369A0 (en) Pharmaceutical complex.
ATE277924T1 (de) Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression
WO2002072883A3 (de) Nukleotidträger zur diagnose und therapie oraler erkrankungen
MXPA03007242A (es) Delta-1-pirrolinas para control de pestes.
NZ505085A (en) Pharmaceutical compositions comprising bipapcitide monocarboxylate and/or bipapcitide dicarboxylate for imaging and treating thrombi
ZA996936B (en) Railbreak indicating arrangement.
Kang et al. Haplotype analysis of the apoB gene in Hypertensives
GB9827270D0 (en) G.c.t.s.
TW396834U (en) An improvement on the smokeproof mask